Clinical Journal of the American Society of Nephrology : CJASN · 6 authors, 7 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
It found that racial/ethnic disparities in excess deaths present early in the pandemic were reversed after the widespread deployment of COVID-19 vaccines, with the highest percentage of excess deaths shifting from Hispanic and Black patients to White patients.
After vaccine deployment from January 31, 2021 onward, percent excess deaths decreased and reversed: Hispanic (17.4%), Black (19.4%), and White (27.6%) patients. Limitations include the inability to distinguish COVID-19-specific deaths from indirect pandemic effects, restriction to Medicare beneficiaries, and potential model sensitivity. The findings indicate reduced but persistent racial/ethnic disparities in mortality after vaccine availability.
